Target Information
| Target General Infomation | |||||
|---|---|---|---|---|---|
| Target ID |
T95438
|
||||
| Former ID |
TTDNR00670
|
||||
| Target Name |
Excitatory amino acid transporter 2
|
||||
| Gene Name |
SLC1A2
|
||||
| Synonyms |
Glutamate/aspartatetransporter II; Sodium-dependent glutamate/aspartate transporter 2; Solute carrier family 1 member 2; SLC1A2
|
||||
| Target Type |
Research
|
||||
| Function |
Transports L-glutamate and also L- and D-aspartate. Essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft. Acts as a symport by cotransporting sodium.
|
||||
| BioChemical Class |
Dicarboxylate amino acid:cation symporter
|
||||
| UniProt ID | |||||
| Sequence |
MASTEGANNMPKQVEVRMHDSHLGSEEPKHRHLGLRLCDKLGKNLLLTLTVFGVILGAVC
GGLLRLASPIHPDVVMLIAFPGDILMRMLKMLILPLIISSLITGLSGLDAKASGRLGTRA MVYYMSTTIIAAVLGVILVLAIHPGNPKLKKQLGPGKKNDEVSSLDAFLDLIRNLFPENL VQACFQQIQTVTKKVLVAPPPDEEANATSAVVSLLNETVTEVPEETKMVIKKGLEFKDGM NVLGLIGFFIAFGIAMGKMGDQAKLMVDFFNILNEIVMKLVIMIMWYSPLGIACLICGKI IAIKDLEVVARQLGMYMVTVIIGLIIHGGIFLPLIYFVVTRKNPFSFFAGIFQAWITALG TASSAGTLPVTFRCLEENLGIDKRVTRFVLPVGATINMDGTALYEAVAAIFIAQMNGVVL DGGQIVTVSLTATLASVGAASIPSAGLVTMLLILTAVGLPTEDISLLVAVDWLLDRMRTS VNVVGDSFGAGIVYHLSKSELDTIDSQHRVHEDIEMTKTQSIYDDMKNHRESNSNQCVYA AHNSVIVDECKVTLAANGKSADCSVEEEPWKREK |
||||
| Inhibitor | DL-TBOA | Drug Info | [534556] | ||
| SYM2081 | Drug Info | [534384] | |||
| threo-3-methylglutamate | Drug Info | [534384] | |||
| WAY-213613 | Drug Info | [527637] | |||
| Modulator | [3H](2S,4R)-4-methylglutamate | Drug Info | [543967] | ||
| [3H]D-aspartic acid | Drug Info | [543967] | |||
| [3H]ETB-TBOA | Drug Info | [528479] | |||
| [3H]L-aspartic acid | Drug Info | [543967] | |||
| Pathways | |||||
| PANTHER Pathway | Ionotropic glutamate receptor pathway | ||||
| Metabotropic glutamate receptor group III pathway | |||||
| WikiPathways | Amyotrophic lateral sclerosis (ALS) | ||||
| References | |||||
| Ref 527637 | Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2. Mol Pharmacol. 2005 Oct;68(4):974-82. Epub 2005 Jul 13. | ||||
| Ref 528479 | Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters. Mol Pharmacol. 2007 Jan;71(1):294-302. Epub 2006 Oct 17. | ||||
| Ref 534384 | Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol Pharmacol. 1997 May;51(5):809-15. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.